Unspecified Adult Solid Tumor, Protocol Specific

  • user warning: Table './intheclinic/captcha_sessions' is marked as crashed and should be repaired query: INSERT into captcha_sessions (uid, sid, ip_address, timestamp, form_id, solution, status, attempts) VALUES (0, '4bv9kqaoigjteevflasamb9lm2', '38.107.191.118', 1268191439, 'user_login_block', 'undefined', 0, 0) in /persistent/html/sites/all/modules/captcha/captcha.inc on line 92.
  • user warning: Table './intheclinic/captcha_sessions' is marked as crashed and should be repaired query: SELECT status FROM captcha_sessions WHERE csid = 0 in /persistent/html/sites/all/modules/captcha/captcha.inc on line 112.
  • user warning: Table './intheclinic/captcha_sessions' is marked as crashed and should be repaired query: SELECT status FROM captcha_sessions WHERE csid = 0 in /persistent/html/sites/all/modules/captcha/captcha.inc on line 112.
  • user warning: Table './intheclinic/captcha_sessions' is marked as crashed and should be repaired query: UPDATE captcha_sessions SET timestamp=1268191439, solution='1' WHERE csid=0 in /persistent/html/sites/all/modules/captcha/captcha.inc on line 104.

Aerobic Exercise in Patients Receiving Chemotherapy for Cancer

Recruitment status: 
Completed

RATIONALE: Aerobic exercise may help prevent side effects caused by chemotherapy and help improve heart health. PURPOSE: This randomized clinical trial is studying the side effects of aerobic exercise and to see how well it works in patients receiving chemotherapy for cancer.

Background information
Trial ID: 
NCT00728429
Other unique IDs: 
CDR0000601334
CCCWFU-99108
CCCWFU-IRB-IRB00006209
Official title: 

CCCWFU 99108 - Effect of Exercise Training in Patients Receiving Anthracycline Drugs - A Pilot Study

Detailed description: 

OBJECTIVES:

  • To determine if patients with cancer can exercise safely and routinely, under supervision, while receiving anthracycline chemotherapy.
  • To determine the magnitude of the change in the peak ventilatory oxygen uptake (VO2) before and after completion of anthracycline chemotherapy with concurrent exercise versus without exercise in patients with cancer.

Number to be enrolled: 
28 patients

Radiation Therapy in Treating Patients With Metastatic Spinal Cord Compression

Recruitment status: 
Recruiting

RATIONALE: Radiation therapy uses high-energy x-rays to kill tumor cells. It is not yet known which radiation therapy regimen is more effective in treating metastatic spinal cord compression. PURPOSE: This randomized clinical trial is comparing two radiation therapy regimens to see how well they work in treating patients with metastatic spinal cord compression.

Background information
Trial ID: 
NCT00727584
Other unique IDs: 
CDR0000599886
CRUK-UCL-BRD/07/010
CRUK-SCORAD
ISRCTN97555949
EU-20863
Official title: 

SCORAD: A Randomised Feasibility Study of Single Fraction Radiotherapy Compared to Multi-Fraction Radiotherapy in Patients With Metastatic Spinal Cord Compression

Detailed description: 

OBJECTIVES:

  • To examine whether a phase III randomized study comparing a single-fraction of radiotherapy with multi-fraction radiotherapy is acceptable to clinicians and to patients with metastatic spinal cord compression.
  • To determine the feasibility of conducting this study in the United Kingdom.

Number to be enrolled: 
100 patients

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

Recruitment status: 
Recruiting

RATIONALE: Methadone, morphine, or oxycodone may help relieve pain caused by cancer. It is not yet known whether methadone is more effective than morphine or oxycodone in treating pain in patients with cancer. PURPOSE: This randomized clinical trial is studying methadone to see how well it works compared with morphine or oxycodone in treating pain in patients with cancer.

Background information
Trial ID: 
NCT00726830
Other unique IDs: 
CDR0000598283
MDA-2007-0791
Official title: 

A Randomized Comparison of Oral Methadone as a "First-Switch" Opioid Versus Opioid Switching Between Sustained-Release Morphine and Oxycodone for Oncology-Hematology Outpatients With Pain Management Problems: The "Simply Rotate" Study

Detailed description: 

OBJECTIVES: Primary

  • To compare the effectiveness of an opioid rotation to oral methadone versus an opioid rotation to another long-acting strong opioid (sustained-release morphine or oxycodone) in controlling pain (i.e., analgesia) in patients with cancer.

Number to be enrolled: 
300 patients

Sirolimus in Treating Patients With Cowden Syndrome or Another Germline Mutation Syndrome

RATIONALE: Sirolimus may stop the growth of abnormal cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well sirolimus works in treating patients with Cowden syndrome or another germline mutation syndrome.

Background information
Other unique IDs: 
CDR0000600867
NCI-08-C-0151
NCI-P07252

American Ginseng in Treating Patients With Fatigue Caused by Cancer

RATIONALE: American ginseng may reduce fatigue in patients with cancer. It is not yet known whether American ginseng is more effective than a placebo in treating cancer-related fatigue. PURPOSE: This randomized phase III trial is studying American ginseng to see how well it works in treating patients with fatigue caused by cancer.

Background information
Other unique IDs: 
CDR0000597665
NCCTG-N07C2

Hydroxychloroquine and Temozolomide in Treating Patients With Metastatic or Unresectable Solid Tumors

RATIONALE: Drugs used in chemotherapy, such as hydroxychloroquine and temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects and best dose of hydroxychloroquine when given together with temozolomide in treating patients with metastatic or unresectable solid tumors.

Background information
Other unique IDs: 
CDR0000600329
UPCC-12907

Morphine After Radiofrequency Ablation of Painful Bone Metastases in Patients With Cancer

Trial phase: 
Phase II
Recruitment status: 
Recruiting

RATIONALE: Morphine may reduce pain in patients who have undergone radiofrequency ablation to remove bone metastases. PURPOSE: This phase II trial is studying how well morphine works after radiofrequency ablation of painful bone metastases in patients with cancer.

Background information
Trial ID: 
NCT00712712
Other unique IDs: 
CDR0000589594
IB-MEDOR
IB-2007-16
INCA-RECF0498
EUDRACT-2007-002686-13
Official title: 

Evaluation of the Effectiveness of the Radiofrequency Ablation for Reducing Refractory Pain From Bone Metastases

Detailed description: 

OBJECTIVES: Primary

  • Measure the efficacy of morphine sulfate at 8 weeks after radiofrequency ablation (RFA) of bone metastases.

Number to be enrolled: 
63 patients

Docetaxel, Oxaliplatin, and Fluorouracil in Treating Patients With Metastatic or Unresectable Stomach Cancer, Gastroesophageal Junction Cancer, or Other Solid Tumor

Trial phase: 
Phase I
Recruitment status: 
Recruiting

RATIONALE: Drugs used in chemotherapy, such as docetaxel, oxaliplatin, and fluorouracil, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Giving more than one drug (combination chemotherapy) may kill more tumor cells. PURPOSE: This phase I/II trial is studying the side effects and best dose of docetaxel when given with oxaliplatin and fluorouracil and to see how well they work in treating patients with metastatic or unresectable stomach cancer, gastroesophageal junction cancer, or other solid tumor.

Background information
Trial ID: 
NCT00711243
Other unique IDs: 
CDR0000599734
NU-0412
SANOFI - AVENTIS-NU0412
NU-948-006
Official title: 

A Phase I/II Study of Taxotere, Oxaliplatin, and 5- Fluorouracil

Detailed description: 

OBJECTIVES: Primary

  • To establish the maximum tolerated dose of docetaxel when administered with oxaliplatin and fluorouracil in patients with metastatic or unresectable solid tumors. (Phase I)
  • To determine the response rate in patients with metastatic or unresectable adenocarcinoma of the stomach or gastroesophageal junction treated with this regimen. (Phase II)

Number to be enrolled: 
73 patients

Screening to Predict Weight Loss in Patients With Cancer

Recruitment status: 
Recruiting

RATIONALE: Screening tests may identify people with cancer who are at high risk of losing weight and help doctors plan better treatment. PURPOSE: This clinical trial is studying how well a new screening tool works in predicting weight loss in patients with cancer.

Background information
Trial ID: 
NCT00710632
Other unique IDs: 
CDR0000590278
QMC-WEIGHT
EU-20831
Official title: 

Predicting Weight Loss in People With Cancer: Development of a Screening Tool

Detailed description: 

OBJECTIVES:

  • To identify people with cancer who are at greatest risk of future weight loss by the development of a simple and practical screening tool.
  • To estimate the reliability of the Appetite and Symptom Questionnaire (part 1).
  • To develop a screening tool based on the ability of the optimal combination of items from the three measures (ASQ, MUST, CRP) to predict clinically significant weight loss over three months (part 2).
  • To estimate the sensitivity and specificity at various cut-points of the developed screening tool in predicting clinically signifi
Number to be enrolled: 
220 patients

Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer

Trial phase: 
Phase III
Recruitment status: 
Recruiting

The purpose of this study is to find out the effects (good and bad) Alpha-Lipoic Acid (ALA) has on preventing a side effect of platinum-containing chemotherapy called peripheral neuropathy. In this study, one group of subjects will receive Alpha-Lipoic Acid (ALA) and another group will receive a placebo control pill. A placebo control pill is a "look-a-like" pill but does not have any medication in it. Another name for placebo pill is "sugar pill." Peripheral neuropathy is an abnormal, uncomfortable, often painful, sensations and feelings in hands or feet. The sensations and feelings in the hands and feet can effect the normal use of the hands and feet, such as in buttoning, writing, typing, sewing, picking up small objects, and walking. Currently there is no standard or reliable therapy to prevent this type of neuropathy. Alpha-Lipoic Acid (ALA) is a dietary supplement that is supposed to prevent or reduce the symptoms.

Background information
Trial ID: 
NCT00705029
Other unique IDs: 
0120070249
Official title: 

Prevention of Cisplatin- or Oxaliplatin-Induced Peripheral Neuropathy With Alpha-Lipoic Acid: A Placebo-Controlled Phase III Trial

Detailed description: 

 

Number to be enrolled: 
244 patients
Syndicate content